Human Stem Cells for Modeling Heart Disease and for Drug Discovery-Reference-Cited by-同舟云学术

Human Stem Cells for Modeling Heart Disease and for Drug Discovery

Published:2014-06-04 Issue:239 Volume:6 Page:
ISSN:1946-6234
Container-title:Science Translational Medicine
language:en
Short-container-title:Sci. Transl. Med.

Author:

Matsa Elena¹²³,Burridge Paul W.¹²³,Wu Joseph C.¹²³

Affiliation:

1. Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA 94305, USA.

2. Department of Medicine, Division of Cardiology, Stanford University School of Medicine, Stanford, CA 94305, USA.

3. Institute of Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.

Abstract

This Perspective highlights recent research progress in the use of stem cells and progenitor cells for disease modeling, drug discovery, and cardiac regeneration.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine

Reference56 articles.

1. The Worldwide Environment of Cardiovascular Disease: Prevalence, Diagnosis, Therapy, and Policy Issues

2. World Health Organization (WHO), World Health Stat. Rep. (2008); http://www.who.int/gho/publications/world_health_statistics/EN_WHS08_Full.pdf.

3. β-Adrenergic Blockade in Cardiovascular Disease

4. c-kit+ cells minimally contribute cardiomyocytes to the heart

5. Cardiomyogenic stem and progenitor cell plasticity and the dissection of cardiopoiesis

Cited by 182 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tudor-SN promotes cardiomyocyte proliferation and neonatal heart regeneration through regulating the phosphorylation of YAP;Cell Communication and Signaling;2024-06-28

2. miR-124-3p downregulates EGR1 to suppress ischemia-hypoxia reperfusion injury in human iPS cell-derived cardiomyocytes;Scientific Reports;2024-06-27

3. Retinoic acid modulation guides human-induced pluripotent stem cell differentiation towards left or right ventricle-like cardiomyocytes;Stem Cell Research & Therapy;2024-06-21

4. Stem cell-based therapy for fibrotic diseases: mechanisms and pathways;Stem Cell Research & Therapy;2024-06-18

5. Replacing Animal Testing with Stem Cell-Organoids : Advantages and Limitations;Stem Cell Reviews and Reports;2024-04-19